These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15045627)

  • 1. Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis.
    Palomo I; Pereira J; Alarcón M; Vásquez M; Pinochet C; Vélez MT; Sandoval J; Icaza G; Pierangeli S
    Clin Rheumatol; 2004 Apr; 23(2):129-33. PubMed ID: 15045627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals.
    Palomo IG; Mujica VE; Alarcón ML; Pereira JG; Vásquez MR
    J Diabetes Complications; 2005; 19(3):133-7. PubMed ID: 15866057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Val/Leu247 and Trp/Ser316 polymorphisms in beta 2 glycoprotein I and their association with thrombosis in unselected Chilean patients.
    Palomo I; Pereira J; Alarcón M; Vásquez M; Pinochet C; Poblete F; Mendez E; Sandoval J; Vidal R; Pierangeli S
    Clin Rheumatol; 2007 Mar; 26(3):302-7. PubMed ID: 16724168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
    Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antiphospholipid antibodies in Chilean patients with rheumatoid arthritis.
    Palomo I; Pinochet C; Alarcón M; Sandoval R; Gonzalez J; Monsalves F; Forastiero R
    J Clin Lab Anal; 2006; 20(5):190-4. PubMed ID: 16960897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and isotype distribution of antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus (SLE).
    Aguirre V; Cuchacovich R; Barria L; Aris H; Trejo C; Massardo L; Pasten R; Espinoza L
    Lupus; 2001; 10(2):75-80. PubMed ID: 11237129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis.
    Deeb A; Hamdoun S; Dababo K
    Iran J Immunol; 2009 Sep; 6(3):154-9. PubMed ID: 19801789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
    Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
    Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
    Marie I; Jouen F; Hellot MF; Levesque H
    Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases.
    Lakos G; Kiss E; Regeczy N; Tarjan P; Soltesz P; Zeher M; Bodolay E; Szucs G; Szakony S; Sipka S; Szegedi G
    J Rheumatol; 2000 Apr; 27(4):924-9. PubMed ID: 10782817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relative value of different antiphospholipid antibodies detected in a department of internal medicine: retrospective study of 124 patients].
    Magy N; Gil H; Racadot E; Dupond JL
    Rev Med Interne; 2002 Aug; 23(8):696-702. PubMed ID: 12360751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.